4 results
Approved WMOCompleted
Primary:To assess the safety and tolerability of Firdapse after single and multiple doses Secondary:Part 1 only: To determine the dose-related PK profile of single, escalating doses of Firdapse;Part 2 only: To assess the steady-state plasma PK and…
Approved WMOCompleted
The primary objective is to determine the efficacy of neo-adjuvant chemotherapy to reduce tumour size below 2 cm in diameter and thus enabling conisation.
Approved WMORecruiting
Main objective: response rate and tumour size reduction by neoadjuvant chemotherapy.
Approved WMOPending
Main objective: response rate and tumour size reduction by chemotherapy